389 related articles for article (PubMed ID: 17333608)
1. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
[TBL] [Abstract][Full Text] [Related]
2. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010.
Reekie JM; Levy MH; Richards AH; Wake CJ; Siddall DA; Beasley HM; Kumar S; Butler TG
Med J Aust; 2014 Mar; 200(5):277-80. PubMed ID: 24641153
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey.
Long J; Allwright S; Barry J; Reynolds SR; Thornton L; Bradley F; Parry JV
BMJ; 2001 Nov; 323(7323):1209-13. PubMed ID: 11719410
[TBL] [Abstract][Full Text] [Related]
4. Spread of bloodborne viruses among Australian prison entrants.
Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners--NSW, 1996.
Butler T; Spencer J; Cui J; Vickery K; Zou J; Kaldor J
Aust N Z J Public Health; 1999 Aug; 23(4):377-84. PubMed ID: 10462860
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
[TBL] [Abstract][Full Text] [Related]
7. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
[TBL] [Abstract][Full Text] [Related]
8. Trends in hepatitis B prevalence and associated risk factors among Indigenous and non-Indigenous prison entrants in Australia, 2004 to 2013.
Coles T; Simpson P; Saulo D; Kaldor J; Richards A; Levy M; Wake C; Siddall DA; Harrod ME; Kariminia A; Butler T
Aust N Z J Public Health; 2019 Jun; 43(3):236-240. PubMed ID: 30690821
[TBL] [Abstract][Full Text] [Related]
9. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
11. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
12. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.
Allwright S; Bradley F; Long J; Barry J; Thornton L; Parry JV
BMJ; 2000 Jul; 321(7253):78-82. PubMed ID: 10884256
[TBL] [Abstract][Full Text] [Related]
15. Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis.
Waller KM; De La Mata NL; Kelly PJ; Ramachandran V; Rawlinson WD; Wyburn KR; Webster AC
Med J Aust; 2019 Nov; 211(9):414-420. PubMed ID: 31489635
[TBL] [Abstract][Full Text] [Related]
16. Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico.
Belaunzaran-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; RodrÃguez-RamÃrez S; Sierra-Madero J; Beyrer C
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):524-533. PubMed ID: 28094553
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.
Mohamed HI; Saad ZM; Abd-Elreheem EM; Abd-ElGhany WM; Mohamed MS; Abd Elnaeem EA; Seedhom AE
J Infect Public Health; 2013 Jun; 6(3):186-95. PubMed ID: 23668463
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities.
Hellard ME; Hocking JS; Crofts N
Epidemiol Infect; 2004 Jun; 132(3):409-15. PubMed ID: 15188710
[TBL] [Abstract][Full Text] [Related]
20. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
